Gilead Sciences, Inc.

NASDAQ: GILD    
Share price (5/3/24): $65.33    
Market cap (5/3/24): $81.3 billion
Search in Documents
Key Exhibits
External Links
13 Gilead Sciences, Inc. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Indentures Filter

EX-4.2
from 8-K 38 pages Ninth Supplemental Indenture Gilead Sciences, Inc. and Computershare Trust Company, National Association, as Successor to Wells Fargo Bank, National Association, as Trustee Ninth Supplemental Indenture Dated as of September 14, 2023 Supplementing the Indenture Dated as of March 30, 2011 5.250% Senior Notes Due 2033 5.550% Senior Notes Due 2053
12/34/56
EX-4.1
from 8-K 119 pages Eighth Supplemental Indenture Gilead Sciences, Inc. and Wells Fargo Bank, National Association, as Trustee Eighth Supplemental Indenture Dated as of September 30, 2020 Supplementing the Indenture Dated as of March 30, 2011 Floating Rate Notes Due 2021 Floating Rate Notes Due 2023 0.750% Senior Notes Due 2023 1.200% Senior Notes Due 2027 1.650% Senior Notes Due 2030 2.600% Senior Notes Due 2040 2.800% Senior Notes Due 2050
12/34/56
EX-4.9
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 71 pages Seventh Supplemental Indenture Gilead Sciences, Inc. and Wells Fargo Bank, National Association, as Trustee Seventh Supplemental Indenture Dated as of September 21, 2017 Supplementing the Indenture Dated as of March 30, 2011 Floating Rate Notes Due September 2018 Floating Rate Notes Due March 2019 Floating Rate Notes Due September 2019 1.850% Senior Notes Due 2019
12/34/56
EX-4.1
from 8-K 79 pages Sixth Supplemental Indenture Gilead Sciences, Inc. and Wells Fargo Bank, National Association, as Trustee Sixth Supplemental Indenture Dated as of September 20, 2016 Supplementing the Indenture Dated as of March 30, 2011 1.950% Senior Notes Due 2022 2.500% Senior Notes Due 2023 2.950% Senior Notes Due 2027 4.000% Senior Notes Due 2036 4.150% Senior Notes Due 2047
12/34/56
EX-4.1
from 8-K 92 pages Fifth Supplemental Indenture Gilead Sciences, Inc. and Wells Fargo Bank, National Association, as Trustee Fifth Supplemental Indenture Dated as of September 14, 2015 Supplementing the Indenture Dated as of March 30, 2011 1.850% Senior Notes Due 2018 2,550% Senior Notes Due 2020 3.250% Senior Notes Due 2022 3.650% Senior Notes Due 2026 4.600% Senior Notes Due 2035 4.750% Senior Notes Due 2046
12/34/56
EX-4.1
from 8-K 49 pages Fourth Supplemental Indenture Gilead Sciences, Inc. and Wells Fargo Bank, National Association, as Trustee Fourth Supplemental Indenture Dated as of November 17, 2014 Supplementing the Indenture Dated as of March 30, 2011 2.350% Senior Notes Due 2020 3.500% Senior Notes Due 2025 4.500% Senior Notes Due 2045
12/34/56
EX-4.1
from 8-K 48 pages Third Supplemental Indenture Gilead Sciences, Inc. and Wells Fargo Bank, National Association, as Trustee Third Supplemental Indenture Dated as of March 7, 2014 Supplementing the Indenture Dated as of March 30, 2011 2.050% Senior Notes Due 2019 3.700% Senior Notes Due 2024 4.800% Senior Notes Due 2044
12/34/56
EX-4.2
from 8-A12G/A 2 pages Third Amendment to Amended and Restated Rights Agreement
12/34/56
EX-4.1
from 8-K 2 pages Third Amendment to Amended and Restated Rights Agreement
12/34/56
EX-4.1
from 8-K 65 pages Second Supplemental Indenture Gilead Sciences, Inc. and Wells Fargo Bank, National Association, as Trustee Second Supplemental Indenture Dated as of December 13, 2011 Supplementing the Indenture Dated as of March 30, 2011 2.40% Senior Notes Due 2014 3.05% Senior Notes Due 2016 4.40% Senior Notes Due 2021 5.65% Senior Notes Due 2041
12/34/56
EX-4.2
from 8-K 20 pages First Supplemental Indenture Gilead Sciences, Inc. and Wells Fargo Bank, National Association, as Trustee First Supplemental Indenture Dated as of March 30, 2011 Supplementing the Indenture Dated as of March 30, 2011
12/34/56
EX-4.1
from 8-K 79 pages Gilead Sciences, Inc. as Corporation Wells Fargo Bank, National Association as Trustee Indenture Dated as of March 30, 2011 Senior Debt Securities Cross-Reference Sheet
12/34/56
EX-4.10
from S-3ASR 79 pages Gilead Sciences, Inc. as Corporation Wells Fargo Bank, National Association as Trustee Indenture Dated as of [ ], 2011 Senior Debt Securities Cross-Reference Sheet
12/34/56
EX-4.3
from S-3ASR 2 pages Specimen Common Stock Certificate
12/34/56
EX-4.2
from 8-K 102 pages Gilead Sciences, Inc. 1.625% Convertible Senior Notes Due 2016 Indenture Dated as of July 30, 2010 Wells Fargo Bank, National Association, Trustee
12/34/56
EX-4.1
from 8-K 102 pages Gilead Sciences, Inc. 1.00% Convertible Senior Notes Due 2014 Indenture Dated as of July 30, 2010 Wells Fargo Bank, National Association, Trustee
12/34/56
EX-4.7
from S-8 1 page Second Amendment to Amended and Restated Rights Agreement
12/34/56
EX-4.3
from 8-K 22 pages Registration Rights Agreement Dated as of April 25, 2006, by and Among Gilead Sciences, Inc. and Merrill Lynch, Pierce, Fenner & Smith, Incorporated, Morgan Stanley & Co. Incorporated and Banc of America Securities LLC, as Representatives of the Several Initial Purchasers Registration Rights Agreement
12/34/56
EX-4.2
from 8-K 83 pages Gilead Sciences, Inc. 0.625% Convertible Senior Notes Due 2013 Indenture Dated as of April 25, 2006 Wells Fargo Bank, National Association, Trustee Cross Reference Table*
12/34/56